bluebird bio (NASDAQ: BLUE)reported first-quarter earnings last week, but like the biotech typically does, management didn't hold a conference call, which makes the earnings release more of a rehash of the quarter than an actual update.
bluebird bio Looks for Data Ahead
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться